Genmab — April 2020

[Bulder]

We understand the available data have been submitted for peer-reviewed publication, which will provide more detailed information from this study in the near future. There are multiple ongoing Phase 3 studies that are designed to provide the additional data needed to determine the potential for remdesivir as a treatment for COVID-19. These studies will help inform whom to treat, when to treat and how long to treat with remdesivir. forts.

[Bulder]

The studies are either fully enrolled for the primary analysis or on track to fully enroll in the near future. slut

[Bulder]

Det drejer sig altså om et af de kinesiske studier (svær covid19), som blev afbrudt forleden pga manglende rekruttering.

[Solsen]

https://medwatch.dk/Medicinal___Biotek/article12095672.ece MedWatch på rem

[bibob]

God morgen.

[E_L]

Blood article : Daratumumab, Lenalidomide, Bortezomib, & Dexamethasone for Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN https://ashpublications.org/blood/article-abstract/doi/10.1182/blood.2020005288/454474/Daratumumab-Lenalidomide-Bortezomib-amp?redirectedFrom=fulltext

[E_L]

if i am not mistaken this is the data we saw at ASH?

[E_L]

insurance companies are proactively calling patients asking them to get daratumumab home infusion.... https://twitter.com/dhughesPharmD/status/1253383729172668416

[bibob]

E L. 07.52. I think you are right. - Submitted : February 13 . 2020. - Revision received : March 31. 2020. - Accepted: April 3. 2020.

[E_L]

ok, correct. also just checked with Genmab presentation. So that is really summer 2019 data i guess. Time for an ASCO update

[Sukkeralf]

ASCO could be huge for Genmab this year

[E_L]

i was wondering about that last weekend, probably a lot of various Dara regime updates? why do you think it would be huge?

[Bulder]

Don't forget tak-079.

[Sukkeralf]

hopefully dara in amyloidosis and if we are lucky also tisotumab vedotin and further updates on epcoritamab

[E_L]

yes, i was thinking the same. amyloidosis would even be a disappointment if it wouldn't be there . we'll get some insight next week.

[Sukkeralf]

Hopefully updates on JNJ Duobodies - at least JNJ61186372 would be nice

[Sukkeralf]

If they are going to file this year - maybe data at ESMO is more likely

[Bulder]

Ritzau: Sanofi skriver i regnskabet, at omkring halvdelen af væksten i første kvartal skyldes virusudbruddet, der har medvirket til, at distributionsled og patienter har opbygget ekstra forråd af medicin. - Kan måske få betydning for forbigående flotte salgstal for dara?

[E_L]

it is possible. But I can't remember JNJ mentioning it in their Q1. What do you think of 08:16, you have called for home infusion for a while...

[Bulder]

Min pointe er, at vi ikke skal falde i svime over eventuelle høje recept/salgs-tal i den kommende tid. Det kan være hamstring.